Lyrica (pregabalin) oral solution launched

on the 2 July 2012

An oral liquid formulation of Lyrica (pregabalin) is now available from Pfizer.

Pregabalin is a GABA analogue that binds to voltage-gated calcium channels in the central nervous system | SCIENCE PHOTO LIBRARY
Pregabalin is a GABA analogue that binds to voltage-gated calcium channels in the central nervous system | SCIENCE PHOTO LIBRARY

Originally licensed as an adjunctive therapy for partial seizures with or without secondary generalisation, the gamma-aminobutyric acid (GABA) analogue is also licensed for generalised anxiety disorder and for the treatment of peripheral and central neuropathic pain.

The oral solution contains 20mg pregabalin per ml. It is available in a 473ml bottle pack and also contains a graduated oral syringe with adaptor.

View Lyrica Oral Solution drug record

Further information: Pfizer

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more